WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

D DERMATOLOGICALS

Most of the drugs in this group are preparations for topical use. Some few preparations for systemic use with clear dermatological applications, e.g. griseofulvin (antimycotic), retinoids (for treatment of acne) and psoralens and retinoids (for treatment of psoriasis) are classified in this group.

Only oral preparations in ATC group D are given DDDs. Most products in this group are for topical use, and no DDDs are assigned because the amount given per day can vary very much according to the intensity and distribution of the disease. Consumption figures for these dermatological preparations can be expressed in grams of preparations regardless of strength.


D01 ANTIFUNGALS FOR DERMATOLOGICAL USE

This group comprises preparations for topical and systemic treatment of dermatological mycoses. Preparations with systemic antimycotic effect, see also J02A - Antimycotics for systemic use.
Topical preparations used especially in gynecological infections are classified in G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids or G01B - Antiinfectives/antiseptics in combination with corticosteroids. Preparations for local treatment of fungal infections in the mouth, see A01AB - Antiinfectives and antiseptics for local oral treatment.


D01A ANTIFUNGALS FOR TOPICAL USE

Combined preparations are classified in this group if mycosis is the main indication.


D01AA Antibiotics

Preparations used in the treatment of bacterial dermatological infections, see D06A - Antibiotics for topical use.


    ATC code  Name  DDD  U Adm.R Note
    D01AA04 pecilocin    

List of abbreviations

Last updated: 2024-01-26